ETF Exchange > ARCX:IDNA ETF
ARCX:IDNA - ETF Fact Sheet
iShares Genomics Immunology and Healthcare ETF - USD
Fund Identification
Ticker
ARCX:IDNA
ISIN
US46435U1925
Main Metrics
Price
$29.47Expense Ratio
0.47%AuM
$160.64MTracking Difference
-0.39%Ratings
Trackinsight rating
★★★★★ESG Consensus®
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise
Official Investment Strategy
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.
ARCX:IDNA's historical prices, performance, and flows
1m returns
-4.25%
1m flows
$1M
* Net total returns
All data as of 22 May 2026
The ETF Exchange is brought to you by
With data and analysis by
See all ARCX:IDNA data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
ARCX:IDNA's characteristics
Manager
Manager statistics
1757 funds, $6,236.79Bn in AUM
Benchmark
NYSE FactSet Global Genomics and Immuno Biopharma Index NTR - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
Meets ESG criteria
No
ARCX:IDNA's exposure
Countries
USA
63.46%
France
8.87%
Other
27.66%
Sectors
Health Care
90.91%
Other
9.09%
Top 5 holdings
Other
9.06%
MODERNA INC
6.75%
ARCELLX
5.36%
IPSEN PROMESSES
4.79%
TAKEDA PHARMACEUTICAL
4.62%
Total holdings
41
Total weight of top 5
30.58%
